Alan D Friedman

8PUBLICATIONS
2CO-AUTHORS
Molecular targetsPredictive and prognostic markersInnate immunityInfant and child healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 07, 2026
A Transgenic mouse tolerant to syngeneic cancer cells expressing truncated human epidermal growth factor receptor.

|Feb 04, 2025
PSMA antibody, humanized PSMA.CAR10.3, or Cetuximab increases prostate cancer localization of NF-κB p50-deficient immature myeloid cells (p50-IMC) and phagocytosis by their macrophage progeny.

Mohammad A Alzubi, Theresa Barberi, Alan D Friedman

|Jan 22, 2021
Adoptive transfer of immature myeloid cells lacking NF-κB p50 (p50-IMC) impedes the growth of MHC-matched high-risk neuroblastoma.

Cheng Cui, Theresa Barberi, Rahul Suresh

|Dec 17, 2020
C/EBPα induces Ebf1 gene expression in common lymphoid progenitors.

Theresa Barberi, Cheng Cui, Alan D Friedman

|Jan 16, 2020
NF-κB p50-deficient immature myeloid cell (p50-IMC) adoptive transfer slows the growth of murine prostate and pancreatic ductal carcinoma.

Rahul Suresh, David J Barakat, Theresa Barberi

|May 24, 2019
HoxA9 binds and represses the Cebpa +8 kb enhancer.

Lei Peng, Hong Guo, Peilin Ma

Pageof 2

Frequent Collaborators

1 joint publications

Mohammad A Alzubi

1 joint publications

Theresa Barberi